Previous Article | Next Article ![]()
Infection and Immunity, December 2001, p. 7271-7276, Vol. 69, No. 12
Max-Planck-Institute for Immunobiology,
Freiburg,1 Institute for Immunology,
University of Greifswald, Greifswald,2 and
Institute for Pathology/Tumor Immunology, University of
Regensburg, Regensburg,3 Germany
Received 8 June 2001/Returned for modification 13 July
2001/Accepted 20 August 2001
Loss, reduction, or enhancement of the ability to respond to
bacterial lipopolysaccharide (LPS) has no influence on survival of mice
in a model of postoperative polymicrobial septic peritonitis induced by
cecal ligation and puncture (CLP). This was demonstrated by using
either mice with a defective Tlr4 gene, which encodes the critical receptor molecule for LPS responses, or mice deficient for
LPS binding protein (LBP) or mice sensitized to LPS by
Propionibacterium acnes. Though interleukin-12 (IL-12)
and gamma interferon (IFN-
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7172-7276.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Differences in Innate Defense Mechanisms in
Endotoxemia and Polymicrobial Septic Peritonitis
) play an important role in the
sensitivity to LPS as well as in the resistance to several infections,
loss of these cytokine pathways does not affect survival after CLP.
Thus, neutralization of neither endogenous IL-12 nor IFN-
altered
mortality. In addition, IFN-
receptor-deficient mice demonstrated
the same sensitivity to CLP as mice with a functional IFN-
receptor.
However, administration of IFN-
at the time of operation or
pretreatment of both IFN-
-sensitive and IFN-
-resistant mice with
IL-12 significantly enhanced mortality. This indicates that in the
present infection model activation of innate defense mechanisms is not
dependent on LPS recognition and does not require endogenous IL-12 or
IFN-
function. Indeed, exogenous application of these two mediators
had deleterious effects.
*
Corresponding author. Mailing address: Institute of
Pathology/Tumor Immunology, University of Regensburg,
F.-J.-Strauss-Allee, D-93042 Regensburg, Germany. Phone:
49.941.944-6622. Fax: 49.941.944-6602. E-mail:
daniela.maennel{at}klinik.uni-regensburg.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|